16 results on '"Raad, Julia"'
Search Results
2. Recent progress in membrane distillation configurations powered by renewable energy sources and waste heat
- Author
-
Moreira, Victor Rezende, Raad, Julia Vieira, Lazarini, Julia Xavier, Santos, Lucilaine V.S., and Amaral, Míriam C.S.
- Published
- 2023
- Full Text
- View/download PDF
3. Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study
- Author
-
Staessen, Jan A, Wendt, Ralph, Yu, Yu-Ling, Kalbitz, Sven, Thijs, Lutgarde, Siwy, Justyna, Raad, Julia, Metzger, Jochen, Neuhaus, Barbara, Papkalla, Armin, von der Leyen, Heiko, Mebazaa, Alexandre, Dudoignon, Emmanuel, Spasovski, Goce, Milenkova, Mimoza, Canevska-Taneska, Aleksandra, Lazo, Mercedes Salgueira, Psichogiou, Mina, Rajzer, Marek W, Fulawka, Lukasz, Dzitkowska-Zabielska, Magdalena, Weiss, Guenter, Feldt, Torsten, Stegemann, Miriam, Normark, Johan, Zoufaly, Alexander, Schmiedel, Stefan, Seilmaier, Michael, Rumpf, Benedikt, Banasik, Mirosław, Krajewska, Magdalena, Catanese, Lorenzo, Rupprecht, Harald, Czerwienska, Beata, Peters, Björn, Nilsson, Åsa, Rothfuss, Katja, Lübbert, Christoph, Mischak, Harald, Beige, Joachim, Ermisch, Jörg, Kellner, Nils, Peruth-Stutzmann, Lydia, Schroth, Stefanie, Schmidt, Jonathan, Schmidt, Ulrike, Breuer, Daniel, Abeud, Fariza, Fournier, Marie-Celine, Louadah, Badr, Molas, Rocio, Rojas, Fraile Loreto, García, Fabiola Alonso, Sánchez, Isabel Garcia, Hrom, Ioana Cezara, Więczek., Andrzej, Schwab, Matthias, K Asayama, Kei, Hansen, Tine W, Maestre, Gladys E, Basoulis, Dimitrios, Karamanakos., Georgios, Lis, Pawel, Olszanecka, Agnieszka, Bellmann-Weiler, Rosa, Lanser, Lucas, Edin, Alicia, Forsell, Matthias NE, Stegmayr, Bernd, Jensen, Björn-Erik Ole, Orth, Hans-Martin, Borstel, Sylke, Mikolajewska, Agata, Hecking, Manfred, Schmölz, Lukas, Hoffmann, Michał, Narkiewicz, Krzysztof, Matera-Witkiewicz, Agnieszka, Zachciał, Justyna, Litwin, Monika, Marciniak, Patrycja, Salgueira Lazo, Mercedes, Fuławka, Łukasz, Rupprecht, Harald D, and Czerwieńska, Beata
- Published
- 2022
- Full Text
- View/download PDF
4. Small peptide CSF fingerprint of amyotrophic lateral sclerosis
- Author
-
Lumi, Rea, primary, Petri, Susanne, additional, Siwy, Justyna, additional, Latosinska, Agnieszka, additional, Raad, Julia, additional, Zürbig, Petra, additional, Skripuletz, Thomas, additional, Mischak, Harald, additional, and Beige, Joachim, additional
- Published
- 2024
- Full Text
- View/download PDF
5. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients
- Author
-
Wendt, Ralph, Thijs, Lutgarde, Kalbitz, Sven, Mischak, Harald, Siwy, Justyna, Raad, Julia, Metzger, Jochen, Neuhaus, Barbara, Leyen, Heiko von der, Dudoignon, Emmanuel, Mebazaa, Alexandre, Spasovski, Goce, Milenkova, Mimoza, Canevska-Talevska, Aleksandra, Czerwieńska, Beata, Wiecek, Andrzej, Peters, Björn, Nilsson, Åsa, Schwab, Matthias, Rothfuss, Katja, Lübbert, Christoph, Staessen, Jan A., and Beige, Joachim
- Published
- 2021
- Full Text
- View/download PDF
6. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
- Author
-
Weissinger, Eva M., Metzger, Jochen, Schleuning, Michael, Schmid, Christoph, Messinger, Diethelm, Beutel, Gernot, Wagner-Drouet, Eva-Maria, Schetelig, Johannes, Baurmann, Herrad, Rank, Andreas, Stolzl, Friedrich, Schäfer-Eckart, Kerstin, Westphal, Karin, Bethge, Wolfgang, von Harsdorf, S., Bunjes, Donald W., Heidenreich, Daniela, Klein, Stefan, Holler, Ernst, Kreipe, Hans H., Jonigk, Danny, Türüchanow, Irina, Raad, Julia, Papkalla, Armin, von der Leyen, Heiko, Hambach, Lothar, Hamwi, Iyas, Ehrlich, Steve, Krauter, Jurgen, Stadler, Michael, and Ganser, Arnold
- Published
- 2021
- Full Text
- View/download PDF
7. OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients
- Author
-
Yu, Yu Ling, Huang, Qi Fang, An, De Wei, Raad, Julia, Martens, Dries S., Latosinska, Agnieszka, Stolarz-Skrzypek, Katarzyna, Van Cleemput, Johan, Feng, Ying Qing, Mischak, Harald, Allegaert, Karel, Verhamme, Peter, Janssens, Stefan, Nawrot, Tim S., Staessen, Jan A., Yu, Yu Ling, Huang, Qi Fang, An, De Wei, Raad, Julia, Martens, Dries S., Latosinska, Agnieszka, Stolarz-Skrzypek, Katarzyna, Van Cleemput, Johan, Feng, Ying Qing, Mischak, Harald, Allegaert, Karel, Verhamme, Peter, Janssens, Stefan, Nawrot, Tim S., and Staessen, Jan A.
- Abstract
Background: Immunosuppressive treatment in heart transplant (HTx) recipient causes osteoporosis. The urinary proteomic profile (UPP) includes peptide fragments derived from the bone extracellular matrix. Study aims were to develop and validate a multidimensional UPP biomarker for osteoporosis in HTx patients from single sequenced urinary peptides identifying the parent proteins. Methods: A single-center HTx cohort was analyzed. Urine samples were measured by capillary electrophoresis coupled with mass spectrometry. Cases with osteoporosis and matching controls were randomly selected from all available 389 patients. In derivation case-control dataset, 1576 sequenced peptides detectable in ≥30 % of patients. Applying statistical analysis on these, an 18-peptide multidimensional osteoporosis UPP biomarker (OSTEO18) was generated by support vector modeling. The 2 replication datasets included 118 and 94 patients. For further validation, the whole cohort was analyzed. Statistical methods included logistic regression and receiver operating characteristic curve (ROC) analysis. Results: In derivation dataset, the AUC, sensitivity and specificity of OSTEO18 were 0.83 (95 % CI: 0.76–0.90), 74.3 % and 87.1 %, respectively. In replication datasets, results were confirmatory. In the whole cohort (154 osteoporotic patients [39.6 %]), the ORs for osteoporosis increased (p < 0.0001) across OSTEO18 quartiles from 0.39 (95 % CI: 0.25–0.61) to 3.14 (2.08–4.75). With full adjustment for known osteoporosis risk factors, OSTEO18 improved AUC from 0.708 to 0.786 (p = 0.0003) for OSTEO18 categorized (optimized threshold: 0.095) and to 0.784 (p = 0.0004) for OSTEO18 as continuously distributed classifier. Conclusion: OSTEO18 is a clinically meaningful novel biomarker indicative of osteoporosis in HTx recipients and is being certified as in-vitro diagnostic.
- Published
- 2024
8. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
- Author
-
Zimmermann, Silke, Rädisch, Brit, Hävemeier, Anika, Busmann, Annette, Wittkop, Ulrike, Neuhaus, Barbara, Ax-Smolarski, Regina, Zieglschmid, Veit, Bollweber, Eva, Wölk, Heidrun, Curovic, Viktor R., Tougaard, Ninna H., Eickhoff, Mie K., Pilemann-Lyberg, Sascha, Winther, Signe A., Rosenlund, Signe V., Hansen, Tine W., von Scholten, Bernt J., Hansen, Christian S., Zobel, Emilie H., Laursen, Jens C., Theilade, Simone, Jelstrup, Lone, Juhl, Tina R., Riis, Dorthe, Hermann, Jessie A., Lundgaard, Anne G., Halkjær, Maja L.D., Aabo, Lene, Frost Lerche, Therese, Lajer, Maria, Stefansen, Rikke J., Campbell, Maria A., Durban, Annika, Raad, Julia, Prigge, Michael, Schiemann, Marco, Wilson, Robbie, Kean, Sharon, Douglas, Elizabeth, Surtees, Pamela, Gant, Christina, Yeung, Stanley M.H., Hagedoorn, Ilse, Flynn, Joanne, Galloway, Joe, Brooksbank, Katriona, Aparicio, Carolina, Iliev, Ilian P., Nones, Francesco, Lo Bue, Francesca, Melacini, Daniela, Cugini, Daniela, Prandini, Silvia, Lecchi, Verusca, Yakymchuk, Svitlana, Gherardi, Giulia, Villa, Alessandro, Villa, Davide, Gaspari, Flavio, Cannata, Antonio N., Ferrari, Silvia, Stucchi, Nadia, Albrechtová, Šárka, Eldeik, Elina, Amanaki, Renata, Fernandez-Fernandez, Beatriz, Sanchez-Rodriguez, Jinny, Vázquez, Clotilde, Sanz, Ana B., Sanchez-Niño, Maria D., Ramos, Adrian M., Gonzalo, Maria Á., Schmidt, Ulrike, Selim, Gjulsen, Gjorgovski, Tatjana, Stratrova, Slavica S., Stojceva-Taneva, Olivera, Schutten-Westerneng, Petra, Wierbos, Brenda, Huvers, Frank, De Bruin, Anneke K., Lapauw, Bruno, de Man, Elsie, Rokegem, Kelly, Inion, Sabien, Kreutzmann, Kristin, Dewettinck, Isabelle, Boukens-de Graaf, Caroline, Clerc-de Jong, Ferrina, Entius, Jannet, Nannings, Marian, van Steenderen, Suzy, Petry, Friedrich W., Kilic, Ceyda, Tofte, Nete, Lindhardt, Morten, Adamova, Katarina, Bakker, Stephan J L, Beige, Joachim, Beulens, Joline W J, Birkenfeld, Andreas L, Currie, Gemma, Delles, Christian, Dimos, Ingo, Francová, Lidmila, Frimodt-Møller, Marie, Girman, Peter, Göke, Rüdiger, Havrdova, Tereza, Heerspink, Hiddo J L, Kooy, Adriaan, Laverman, Gozewijn D, Mischak, Harald, Navis, Gerjan, Nijpels, Giel, Noutsou, Marina, Ortiz, Alberto, Parvanova, Aneliya, Persson, Frederik, Petrie, John R, Ruggenenti, Piero L, Rutters, Femke, Rychlík, Ivan, Siwy, Justyna, Spasovski, Goce, Speeckaert, Marijn, Trillini, Matias, Zürbig, Petra, von der Leyen, Heiko, and Rossing, Peter
- Published
- 2020
- Full Text
- View/download PDF
9. Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection : a prospective multicentre cohort study
- Author
-
Staessen, Jan A., Wendt, Ralph, Yu, Yu-Ling, Kalbitz, Sven, Thijs, Lutgarde, Siwy, Justyna, Raad, Julia, Metzger, Jochen, Neuhaus, Barbara, Papkalla, Armin, von der Leyen, Heiko, Mebazaa, Alexandre, Dudoignon, Emmanuel, Spasovski, Goce, Milenkova, Mimoza, Canevska-Taneska, Aleksandra, Salgueira Lazo, Mercedes, Psichogiou, Mina, Rajzer, Marek W., Fuławka, Łukasz, Dzitkowska-Zabielska, Magdalena, Weiss, Guenter, Feldt, Torsten, Stegemann, Miriam, Normark, Johan, Zoufaly, Alexander, Schmiedel, Stefan, Seilmaier, Michael, Rumpf, Benedikt, Banasik, Mirosław, Krajewska, Magdalena, Catanese, Lorenzo, Rupprecht, Harald D., Czerwieńska, Beata, Peters, Björn, Nilsson, Åsa, Rothfuss, Katja, Lübbert, Christoph, Mischak, Harald, Beige, Joachim, Staessen, Jan A., Wendt, Ralph, Yu, Yu-Ling, Kalbitz, Sven, Thijs, Lutgarde, Siwy, Justyna, Raad, Julia, Metzger, Jochen, Neuhaus, Barbara, Papkalla, Armin, von der Leyen, Heiko, Mebazaa, Alexandre, Dudoignon, Emmanuel, Spasovski, Goce, Milenkova, Mimoza, Canevska-Taneska, Aleksandra, Salgueira Lazo, Mercedes, Psichogiou, Mina, Rajzer, Marek W., Fuławka, Łukasz, Dzitkowska-Zabielska, Magdalena, Weiss, Guenter, Feldt, Torsten, Stegemann, Miriam, Normark, Johan, Zoufaly, Alexander, Schmiedel, Stefan, Seilmaier, Michael, Rumpf, Benedikt, Banasik, Mirosław, Krajewska, Magdalena, Catanese, Lorenzo, Rupprecht, Harald D., Czerwieńska, Beata, Peters, Björn, Nilsson, Åsa, Rothfuss, Katja, Lübbert, Christoph, Mischak, Harald, and Beige, Joachim
- Abstract
Background: The SARS-CoV-2 pandemic is a worldwide challenge. The CRIT-CoV-U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression from SARS-CoV-2. After the interim analysis presented for the German Government, here, we aimed to analyse the full dataset to consolidate the findings and propose potential clinical applications of this biomarker. Methods: CRIT-CoV-U was a prospective multicentre cohort study. In eight European countries (Austria, France, Germany, Greece, North Macedonia, Poland, Spain, and Sweden), 1012 adults with PCR-confirmed COVID-19 were followed up for death and progression along the 8-point WHO scale. Capillary electrophoresis coupled with mass spectrometry was used for urinary proteomic profiling. Statistical methods included logistic regression and receiver operating characteristic curve analysis with a comparison of the area under curve (AUC) between nested models. Hospitalisation costs were derived from the care facility corresponding with the Markov chain probability of reaching WHO scores ranging from 3 to 8 and flat-rate hospitalisation costs adjusted for the gross per capita domestic product of each country. Findings: From June 30 to Nov 19, 2020, 228 participants were recruited, and from April 30, 2020, to April 14, 2021, 784 participants were recruited, resulting in a total of 1012 participants. The entry WHO scores were 1–3 in 445 (44%) participants, 4–5 in 529 (52%) participants, and 6 in 38 (4%) participants; and of all participants, 119 died and 271 had disease progression. The odds ratio (OR) associated with COV50 in all 1012 participants for death was 2·44 (95% CI 2·05–2·92) unadjusted and 1·67 (1·34–2·07) when adjusted for sex, age, BMI, comorbidities, and baseline WHO score; and for disease progression, the OR was 1·79 (1·60–2·01) when unadjusted and 1·63 (1·41–1·91) when adjusted (p<0·0001 for all). The predictive accuracy of the optimised COV50
- Published
- 2022
- Full Text
- View/download PDF
10. Predictive Performance and Clinical Application of COV50, A Urinary Proteomic Biomarker in Early COVID-19 Infection: A Cohort Study
- Author
-
Staessen, Jan, primary, Wendt, Ralph, additional, Yu, Yu-Ling, additional, Kalbitz, Sven, additional, Thijs, Lutgarde, additional, Siwy, Justyna, additional, Raad, Julia, additional, Metzger, Jochen, additional, Neuhaus, Barbara, additional, Papkalla, Armin, additional, von der Leyen, Heiko, additional, Mebazaa, Alexandre, additional, Dudoignon, Emmanuel, additional, Spasovski, Goce, additional, Milenkova, Mimoza, additional, Canevska-Tanevska, Aleksandra, additional, Psichogiou, Mina, additional, Rajzer, Marek W., additional, Fulawka, Lukasz, additional, Dzitkowska-Zabielska, Magdalena, additional, Weiss, Günter, additional, Feldt, Torsten, additional, Stegemann, Miriam Songa, additional, Normark, Johan, additional, Zoufaly, Alexander, additional, Schmiedel, Stefan, additional, Seilmaier, Michael, additional, Rumpf, Benedikt, additional, Banasik, Miroslaw, additional, Krajewska, Magdalena, additional, Catanese, Lorenzo, additional, Rupprecht, Harald, additional, Czerwienska, Beata, additional, Peters, Björn, additional, Nilsson, Asa, additional, Rothfuss, Katja, additional, Lübbert, Christoph, additional, Mischak, Harald, additional, Beige, Joachim, additional, and Investigators, CRIT-Cov-U, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Urinary peptides in heart failure:a link to molecular pathophysiology
- Author
-
He, Tianlin, Mischak, Michaela, Clark, Andrew L, Campbell, Ross T., Delles, Christian, Díez, Javier, Filippatos, Gerasimos, Mebazaa, Alexandre, McMurray, John J V, González, Arantxa, Raad, Julia, Stroggilos, Rafael, Bosselmann, Helle S., Campbell, Archie, Kerr, Shona M, Jackson, Colette E, Cannon, Jane A., Schou, Morten, Girerd, Nicolas, Rossignol, Patrick, McConnachie, Alex, Rossing, Kasper, Schanstra, Joost P, Zannad, Faiez, Vlahou, Antonia, Mullen, William, Jankowski, Vera, Mischak, Harald, Zhang, Zhenyu, Staessen, Jan A., Latosinska, Agnieszka, He, Tianlin, Mischak, Michaela, Clark, Andrew L, Campbell, Ross T., Delles, Christian, Díez, Javier, Filippatos, Gerasimos, Mebazaa, Alexandre, McMurray, John J V, González, Arantxa, Raad, Julia, Stroggilos, Rafael, Bosselmann, Helle S., Campbell, Archie, Kerr, Shona M, Jackson, Colette E, Cannon, Jane A., Schou, Morten, Girerd, Nicolas, Rossignol, Patrick, McConnachie, Alex, Rossing, Kasper, Schanstra, Joost P, Zannad, Faiez, Vlahou, Antonia, Mullen, William, Jankowski, Vera, Mischak, Harald, Zhang, Zhenyu, Staessen, Jan A., and Latosinska, Agnieszka
- Abstract
Aims: Heart failure (HF) is a major public health concern worldwide. The diversity of HF makes it challenging to decipher the underlying complex pathological processes using single biomarkers. We examined the association between urinary peptides and HF with reduced (HFrEF), mid-range (HFmrEF) and preserved (HFpEF) ejection fraction, defined based on the European Society of Cardiology guidelines, and the links between these peptide biomarkers and molecular pathophysiology. Methods and results: Analysable data from 5608 participants were available in the Human Urinary Proteome database. The urinary peptide profiles from participants diagnosed with HFrEF, HFmrEF, HFpEF and controls matched for sex, age, estimated glomerular filtration rate, systolic and diastolic blood pressure, diabetes and hypertension were compared applying the Mann–Whitney test, followed by correction for multiple testing. Unsupervised learning algorithms were applied to investigate groups of similar urinary profiles. A total of 577 urinary peptides significantly associated with HF were sequenced, 447 of which (77%) were collagen fragments. In silico analysis suggested that urinary biomarker abnormalities in HF principally reflect changes in collagen turnover and immune response, both associated with fibrosis. Unsupervised clustering separated study participants into two clusters, with 83% of non-HF controls allocated to cluster 1, while 65% of patients with HF were allocated to cluster 2 (P < 0.0001). No separation based on HF subtype was detectable. Conclusions: Heart failure, irrespective of ejection fraction subtype, was associated with differences in abundance of urinary peptides reflecting collagen turnover and inflammation. These peptides should be studied as tools in early detection, prognostication, and prediction of therapeutic response.
- Published
- 2021
12. Urinary peptides in heart failure: a link to molecular pathophysiology
- Author
-
He, Tianlin, primary, Mischak, Michaela, additional, Clark, Andrew L., additional, Campbell, Ross T., additional, Delles, Christian, additional, Díez, Javier, additional, Filippatos, Gerasimos, additional, Mebazaa, Alexandre, additional, McMurray, John J.V., additional, González, Arantxa, additional, Raad, Julia, additional, Stroggilos, Rafael, additional, Bosselmann, Helle S., additional, Campbell, Archie, additional, Kerr, Shona M., additional, Jackson, Colette E., additional, Cannon, Jane A., additional, Schou, Morten, additional, Girerd, Nicolas, additional, Rossignol, Patrick, additional, McConnachie, Alex, additional, Rossing, Kasper, additional, Schanstra, Joost P., additional, Zannad, Faiez, additional, Vlahou, Antonia, additional, Mullen, William, additional, Jankowski, Vera, additional, Mischak, Harald, additional, Zhang, Zhenyu, additional, Staessen, Jan A., additional, and Latosinska, Agnieszka, additional
- Published
- 2021
- Full Text
- View/download PDF
13. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
- Author
-
Weissinger, Eva M., primary, Metzger, Jochen, additional, Schleuning, Michael, additional, Schmid, Christoph, additional, Messinger, Diethelm, additional, Beutel, Gernot, additional, Wagner-Drouet, Eva-Maria, additional, Schetelig, Johannes, additional, Baurmann, Herrad, additional, Rank, Andreas, additional, Stolzl, Friedrich, additional, Schäfer-Eckart, Kerstin, additional, Westphal, Karin, additional, Bethge, Wolfgang, additional, von Harsdorf, S., additional, Bunjes, Donald W., additional, Heidenreich, Daniela, additional, Klein, Stefan, additional, Holler, Ernst, additional, Kreipe, Hans H., additional, Jonigk, Danny, additional, Türüchanow, Irina, additional, Raad, Julia, additional, Papkalla, Armin, additional, von der Leyen, Heiko, additional, Hambach, Lothar, additional, Hamwi, Iyas, additional, Ehrlich, Steve, additional, Krauter, Jurgen, additional, Stadler, Michael, additional, and Ganser, Arnold, additional
- Published
- 2020
- Full Text
- View/download PDF
14. P1457COMPARISON OF PEPTIDOMES BETWEEN URINE, PLASMA, AND HEMODIALYSIS FLUID INDICATES SELECTIVITY IN RENAL PEPTIDE PROCESSING
- Author
-
He, Tianlin, primary, Raad, Julia, primary, Beige, Joachim, primary, and Mischak, Harald, primary
- Published
- 2020
- Full Text
- View/download PDF
15. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
- Author
-
Tofte, Nete, primary, Lindhardt, Morten, additional, Adamova, Katarina, additional, Bakker, Stephan J L, additional, Beige, Joachim, additional, Beulens, Joline W J, additional, Birkenfeld, Andreas L, additional, Currie, Gemma, additional, Delles, Christian, additional, Dimos, Ingo, additional, Francová, Lidmila, additional, Frimodt-Møller, Marie, additional, Girman, Peter, additional, Göke, Rüdiger, additional, Havrdova, Tereza, additional, Heerspink, Hiddo J L, additional, Kooy, Adriaan, additional, Laverman, Gozewijn D, additional, Mischak, Harald, additional, Navis, Gerjan, additional, Nijpels, Giel, additional, Noutsou, Marina, additional, Ortiz, Alberto, additional, Parvanova, Aneliya, additional, Persson, Frederik, additional, Petrie, John R, additional, Ruggenenti, Piero L, additional, Rutters, Femke, additional, Rychlík, Ivan, additional, Siwy, Justyna, additional, Spasovski, Goce, additional, Speeckaert, Marijn, additional, Trillini, Matias, additional, Zürbig, Petra, additional, von der Leyen, Heiko, additional, Rossing, Peter, additional, Zimmermann, Silke, additional, Rädisch, Brit, additional, Hävemeier, Anika, additional, Busmann, Annette, additional, Wittkop, Ulrike, additional, Neuhaus, Barbara, additional, Ax-Smolarski, Regina, additional, Zieglschmid, Veit, additional, Bollweber, Eva, additional, Wölk, Heidrun, additional, Curovic, Viktor R., additional, Tougaard, Ninna H., additional, Eickhoff, Mie K., additional, Pilemann-Lyberg, Sascha, additional, Winther, Signe A., additional, Rosenlund, Signe V., additional, Hansen, Tine W., additional, von Scholten, Bernt J., additional, Hansen, Christian S., additional, Zobel, Emilie H., additional, Laursen, Jens C., additional, Theilade, Simone, additional, Jelstrup, Lone, additional, Juhl, Tina R., additional, Riis, Dorthe, additional, Hermann, Jessie A., additional, Lundgaard, Anne G., additional, Halkjær, Maja L.D., additional, Aabo, Lene, additional, Frost Lerche, Therese, additional, Lajer, Maria, additional, Stefansen, Rikke J., additional, Campbell, Maria A., additional, Durban, Annika, additional, Raad, Julia, additional, Prigge, Michael, additional, Schiemann, Marco, additional, Wilson, Robbie, additional, Kean, Sharon, additional, Douglas, Elizabeth, additional, Surtees, Pamela, additional, Gant, Christina, additional, Yeung, Stanley M.H., additional, Hagedoorn, Ilse, additional, Flynn, Joanne, additional, Galloway, Joe, additional, Brooksbank, Katriona, additional, Aparicio, Carolina, additional, Iliev, Ilian P., additional, Nones, Francesco, additional, Lo Bue, Francesca, additional, Melacini, Daniela, additional, Cugini, Daniela, additional, Prandini, Silvia, additional, Lecchi, Verusca, additional, Yakymchuk, Svitlana, additional, Gherardi, Giulia, additional, Villa, Alessandro, additional, Villa, Davide, additional, Gaspari, Flavio, additional, Cannata, Antonio N., additional, Ferrari, Silvia, additional, Stucchi, Nadia, additional, Albrechtová, Šárka, additional, Eldeik, Elina, additional, Amanaki, Renata, additional, Fernandez-Fernandez, Beatriz, additional, Sanchez-Rodriguez, Jinny, additional, Vázquez, Clotilde, additional, Sanz, Ana B., additional, Sanchez-Niño, Maria D., additional, Ramos, Adrian M., additional, Gonzalo, Maria Á., additional, Schmidt, Ulrike, additional, Selim, Gjulsen, additional, Gjorgovski, Tatjana, additional, Stratrova, Slavica S., additional, Stojceva-Taneva, Olivera, additional, Schutten-Westerneng, Petra, additional, Wierbos, Brenda, additional, Huvers, Frank, additional, De Bruin, Anneke K., additional, Lapauw, Bruno, additional, de Man, Elsie, additional, Rokegem, Kelly, additional, Inion, Sabien, additional, Kreutzmann, Kristin, additional, Dewettinck, Isabelle, additional, Boukens-de Graaf, Caroline, additional, Clerc-de Jong, Ferrina, additional, Entius, Jannet, additional, Nannings, Marian, additional, van Steenderen, Suzy, additional, Petry, Friedrich W., additional, and Kilic, Ceyda, additional
- Published
- 2020
- Full Text
- View/download PDF
16. The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD
- Author
-
Weissinger, Eva M, Jochen, Metzger, Schleuning, Michael, Schmid, Christoph, Messinger, Diethelm, Beutel, Gernot, Wagner, Eva-Maria, Schetelig, Johannes, Baurmann, Herrad, Rank, Andreas, Stolzl, Friedrich, Schäfer-Eckhard, Kerstin, Westphal, Karin, Bethge, Wolfgang, Bunjes, Donald w., Heidenreich, Daniela, Klein, Stefan, Wolff, Daniel, Holler, Ernst, Kreipe, Hans H, Jonigk, Danny, Türüchanow, Irina, Rothmann, Clara, Raad, Julia, Durban, Annika, Hamwi, Iyas, Ehrlich, Steve, Schweier, Patrick, Krauter, Jurgen, Stadler, Michael, and Ganser, Arnold
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.